Overview

An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the safety and tolerability of an investigational drug in patients with Type 2 Diabetes Mellitus (a specific type of diabetes) and Chronic Renal Insufficiency (inadequate kidney function).
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Glipizide
Sitagliptin Phosphate
Criteria
Inclusion Criteria:

- Patients who are at least 18 years of age diagnosed with type 2 diabetes mellitus
(T2DM) (a specific type of diabetes).

- Patient has renal (kidney) insufficiency (inadequate kidney function)

Exclusion Criteria:

- Patient has had heart problems (such as a heart attack or chest pain) or stroke within
the past 6 months or any condition or therapy which, in the opinion of the
investigator, may not be in the patient's best interest to participate.

- Pregnant or breast feeding